This Newsletter Has Been Generously Sponsored By:
Click Above for More Information on Home Phototherapeutic Light Units for Vitiligo

Bibliography for Fall 2013 VSI Newsletter

Agarwal S, Gupta S, Ojha A, Sinha R. (2012) Childhood vitiligo: clinicoepidemiologic profile of 268 children from the Kumaun region of Uttarakhand, India. Pediatric Dermatology. 1-6. DOI: 10.1111/pde.12032.

Akdeniz N, Yavuz IH, Gunes Bilgili S, Ozaydin Yavuz G, Calka O. (2013) Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol and with bethamethasone and calcipotriol in vitiligo. Journal of Dermatology Treatments. 2013 May 6.

Bilgic O, Bilgic A, Akis HK, Eskioǧlu F, Kilic EZ. (2011) Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clinical Experimental Dermatology. 36(4):360-5.

Cho S, Zheng Z, Park YK, Roh MR. (2011) The 308-nm excimer laser: a promising device for the treatment of childhood vitiligo. Photodermatology Photoimmunology Photomedicine. 27(1):24-9.

Cho SB, Kim JH, Cho S, Park JM, Park YK, Oh SH. (2011) Vitiligo in children and adolescents: association with thyroid dysfunction. Journal of European Academy of Dermatology and Venereology. 25(1):64-7.

Clinuvel Press Release “Five month study follow up shows Scenesse® combination treatment provided stable repigmentation in vitiligo patients.” September 2013.

Dertlioǧlu SB, Cicek D, Balci DD, Halisdemir N. (2013) Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects. International Journal of Dermatology. 52(1):96-101.

Do JE, Shin JY, Kim DY, Hann SK, OH SH. (2011) The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Photodermatology Photoimmunology Photomedicine. 27(3):147-51.

Ezzedine K, Diallo A, Léauté-Labréze C, Mossalayi D, Gauthier Y, Bouchtnei S, Cario-André M. (2011) Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. British Journal of Dermatology. 165:44-49.

Ezzedine K, Diallo A, Léauté-Labréze C, Senescal J, Boniface K, Cario-André M, Prey S, Ballanger F, Boralevi F, Jouary T, Mossalayi D, Taieb A. (2012) onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo. British Journal of Dermatology. 167:490-495.

Ezzedine K, Gauthier Y, Léauté-Labréze C, Marquez S, Bouchtnei S, Jouary T, Taieb A. (2010) Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. Journal of the American Academy of Dermatology. 65(5):965-971.

Ho N, Pope E, Weinstein M, Greenberg S, Webster C, Krafchik BR. (2011) A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo. British Journal of Dermatology. 165(3):626-32

Kanwar AJ, Kumaran MS. (2012) Childhood vitiligo: treatment paradigms. Indian Journal of Dermatology. 57(6): 466-474.

Kathuria S, Khaitan BK, Ramam M, Sharma VK. (2012) Segmental vitiligo: a randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream. Indian Journal of Dermatology Venereology Leprosy. 78(1):68-73.

Köse O, Arca E, Kurumlu Z. (2010) Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. Journal of Dermatology Treatments. 21(3): 133-9.

Kroon MW, Vrijman C, Chandeck C, Wind BS, Wolkerstorfer A, Luiten RM, Box JD, Geskkus RB, van Trotsenburg P, van der Veen JP. (2013) High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo. Hormone Research Pediatrics. 79:137-44.

Kruger C, Schallreuter KU. (2013) Cumulative life course impairment in vitiligo. Current Problems in Dermatology. 44:102-17.

Kruger C, Panske A, Schallreuter KU. (2013) Disease-related behavioral patterns and experiences affect quality of life in children and adolescents with vitiligo. International Journal of Dermatology. Doi 10.1111/j. 1365-4632.2012.05656.x. (Epub ahead of print.)

Kumar S, Mittal J, Mahajan B. (2013) Colocalization of vitligo and alopecia areata: coincidence or consequence? International Journal of Trichology. 5(1):50-2.

Lee DY, Kim CR, Lee JH. (2011) Targeted phototherapy in combination with drug therapy for segmental vitiligo. Photodermatology Photoimmunology Photomedicine. 27(2):108-10.

Lin X, Tang LY, Fu WW, Kang KF. (2011) Childhood vitiligo in china. American Journal of Clinical Dermatology. 12(4):277-281.

Matin R. (2011) Vitiligo in adults and children. Clinical Evidence (online). 2011 March 28.

Mazereeuw-Hautier J, Bezio S, Mahe E, Bodemer C, Eschard C, Viseux V, Labreze C, Plantin P, Barbarot S, Vabres P, Martin L, Paul C, Lacour J, Groupe de Recherche Clinique en Dermatologie Pédiatrique (GRCDP). (2010) Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. Journal of American Academy of Dermatology. 62(6): 945-949.

Nicolaidou E, Antoniou C, Miniati A, Lagogianni E, Matekovits A, Stratigos A, Katsambass A. (2012) Childhood-and later-onset vitiligo have diverse epidemiologic and clinical characteristics. Journal of the American Academy of Dermatology. 66(6):954-958.

Palit A, Inamadar A. (2012) Childhood vitiligo. Indian Journal of Dermatology, Venereology and Leprology. 78(1): 30-41.

Park JH, Park SW, Lee DY, Lee JH, Yang JM. (2013) The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration. Photodermatology Photoimmunology Photomedicine. 29(2):103-5.

Percivalle S, Piccinno R, Caccialanza M, Forti S. (2012) Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients. Pediatric Dermatology. 29(2):160-5.

Prćić S, Djuran V, Katanić D, Vlaški J, Gajinov Z. (2011) Vitiligo and thyroid dysfunction in children and adolescents. Acta Dermatovenerology Croatia. 19(4):248-54.

Sampogna F. (2013) Life course impairment and quality of life over time. Current Problems in Dermatology. 44:47-51.

Seyhan M, Erdem T, Ertekin V, Selimoğlu MA. (2007) The mucocutaneous manifestations associated with celiac disease in childhood and adolescence. Pediatric Dermatology. 24(1):28-33.

Shakthisri K, Akhtar N, Ravindran S, Prabhu S, Shenoi S. (2013) Phototherapy in vitiligo: assessing the compliance, response and patient’s perception about disease and treatment. Indian Journal of Dermatology. 58(4):325.

Silverberg N, Lin P, Travis L, Farley-Li J, Mancini A, Wagner A, Chamlin S, Paller A. (2004) Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. Journal of the American Academy of Dermatology. 51(5): 760-766.

Silverberg N. (2010) Update on childhood vitiligo. Current Opinion in Pediatrics. 22(4):445-452.

Tamesis ME, Morelli JG. (2010) Vitiligo treatment in childhood: a state of the art review. Pediatric Dermatology. 27(5):437-45.

Thomas J. (2008) Childhood vitiligo – an overview. Journal of the Indian Society of Teledermatology. 2(4): 1-6.

Udompataikul M, Boonsupthip P, Siriwattanagate R. (2011) Effectiveness of 0.1% topical tacrolimus in adult and children patients with vitiligo. Journal of Dermatology. 38(6):536-40.

Uncu S, Yayh S, Bahadir S, Ökten A, Alpay K. (2011) Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. International Journal of Dermatology. 50:175-179.



Copyright © 2013 Vitiligo Support International Inc. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission

A Vitiligo Support International, Inc. financial statement is available upon written request from the Virginia Office of Consumer Affairs.
Mail requests to: Virginia Department of Agriculture and Consumer Services, Office of Consumer Affairs, P.O. Box 1163, Richmond, Virginia 23218.
Click here to unsubscribe